Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, May 13, 2025 · 812,060,442 Articles · 3+ Million Readers

Ascent Industries Reports First Quarter 2025 Results

May 12, 2025 --

Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), an industrials company focused on the production of specialty chemicals and industrial tubular products, is reporting its results for the first quarter ended March 31, 2025.

First Quarter 2025 Summary1

(in millions, except per share and margin)

Q1 2025

Q1 2024

Change

Net Sales

$24.7

$28.0

(11.8)%

Gross Profit

$4.8

$2.3

108.7%

Gross Profit Margin

19.4%

8.2%

1120bps

Net Loss

($1.0)

$(5.5)

(81.8)%

Diluted Loss per Share

($0.10)

$(0.37)

(73.0)%

Adjusted EBITDA

$0.8

$(2.7)

+$3.5M

Adjusted EBITDA Margin

3.4%

(9.6)%

1300bps

____________________________

1 On April 4, 2025, the Company closed on a transaction to sell substantially all of the assets of Bristol Metals, LLC (“BRISMET”). As a result, financial results from BRISMET have been categorized into discontinued operations.

Management Commentary

“In Q1 2025, we built on our 2024 self‑help initiatives to double gross profit to $4.8 million and expand gross margin by 1,120 basis points to 19.4%, even as net sales held at $24.7 million,” said Ascent CEO Bryan Kitchen. Despite muted demand, our disciplined focus on product-mix optimization, cost management and operational rigor drove Specialty Chemicals Adjusted EBITDA to $2.0 million from a $0.3 million loss and lifted Tubular Products Adjusted EBITDA to $1.3 million, pushing margins toward 20%.

“As we shift from stabilization to growth mode, our team’s disciplined execution is already creating a robust pipeline of high-quality, organic growth opportunities. Although post‑election dynamics can provide additional tailwinds, it’s our strengthened foundation, clear strategy, disciplined operating model and exceptional talent that will carry Ascent toward a predictable, reliable, and profitable business model delivering durable value for our shareholders..”

First Quarter 2025 Financial Results

Net sales from continuing operations were $24.7 million compared to $28.0 million in the first quarter of 2024. The decline was a result of lower volume within both segments partially offset by increased pricing with specialty chemicals.

Gross profit from continuing operations increased 108.7% to $4.8 million, or 19.4% of net sales, compared to $2.3 million, or 8.2% of net sales, in the first quarter of 2024. The increase was primarily driven by continued cost management, improved strategic sourcing, and continued product line optimization.

Net loss from continuing operations improved to ($1.0) million, or ($0.10) diluted loss per share compared to a net loss from continuing operations of ($5.5) million, or ($0.37) diluted loss per share, in the first quarter of 2024.

Adjusted EBITDA increased to $0.8 million compared to $(2.7) million in the first quarter of 2024, with adjusted EBITDA margin increasing to 3.4% compared to (9.6)% in the prior year period. The improvement was primarily driven by the aforementioned cost and product mix optimization initiatives.

Segment Results

Ascent Chemicalsnet sales totaled $17.8 million, compared to $20.3 million in Q1 2024, reflecting a 12.3% decrease. This was the anticipated result of a purposeful shift in product mix that began in 2024, which focused on building a more rateable, predictable and profitable book of business. While this shift led to a decrease in volume, it was offset by higher average selling prices, driving improved profitability in line with our long-term margin enhancement goals. Operating income in the first quarter improved significantly to $0.8 million compared to an operating loss of ($1.4) million in the prior year period. Adjusted EBITDA in the first quarter increased significantly to $2.0 million compared to $(0.3) million in the prior year period. As a percentage of segment net sales, adjusted EBITDA increased significantly to 11.0% compared to (1.4)% in the first quarter of 2024.

Ascent Tubularnet sales from continuing operations in the first quarter of 2025 were $6.9 million compared to $7.7 million in the first quarter of 2024. Operating income from continuing operations in the first quarter increased significantly to $1.0 million compared to an operating loss from continuing operations of ($0.1) million in the prior year period, reflecting reductions in material and labor costs. Adjusted EBITDA from continuing operations in the first quarter increased significantly to $1.3 million compared to $0.3 million in the prior year period. As a percentage of segment net sales, adjusted EBITDA increased significantly to 19.0% compared to 3.5% in the first quarter of 2024.

On April 4, 2025, the Company closed on the sale of substantially all of the assets of Bristol Metals, LLC. ("BRISMET") for a transaction price of $45 million in cash, subject to working capital and other closing adjustments. The sale of BRISMET leaves ASTI as the only remaining asset in the Tubular segment of Ascent.

Liquidity

As of March 31, 2025, the Company had $14.3 million in cash and cash equivalents, no debt outstanding under its revolving credit facilities and had $53.3 million in availability under its revolving credit facility. On April 4, 2025, the Company entered into an amended credit facility associated with the BRISMET transaction reducing its maximum revolving loan commitment. As of April 4, 2025, the Company had $18.8 million of remaining availability under it credit facility.

For the quarter ended March 31, 2025, the Company repurchased 16,822 shares at an average cost of $12.73 per share for approximately $0.2 million.

Conference Call

Ascent will hold a conference call today at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2025.

Ascent management will host the conference call, followed by a question-and-answer period.

Date: Monday, May 12, 2025
Time: 5:00 p.m. Eastern time
Live Call Registration Link: Here
Webcast Registration Link: Here

To access the call by phone, please register via the live call registration link above or here and you will be provided with dial-in instructions and details. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will also be broadcast live and available for replay via the webcast registration link above here. The webcast will be archived for one year in the investor relations section of the Company’s website at www.ascentco.com.

About Ascent Industries Co.

Ascent Industries Co. (Nasdaq: ACNT) is a company that engages in the production of specialty chemicals and stainless steel tubular products. For more information about Ascent, please visit its website at www.ascentco.com.

Forward-Looking Statements

This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks as set forth in more detail in Ascent Industries Co.’s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC or on our website. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release.

Non-GAAP Financial Information

Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.

Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring & severance costs from net income.

Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.

Ascent Industries Co.

Condensed Consolidated Balance Sheets

(in thousands, except par value and share data)

 

 

(Unaudited)

 

 

 

March 31,
2025

 

December 31,
2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

14,272

 

 

$

16,098

 

Accounts receivable, net of allowance for credit losses of $1,169 and $427, respectively

 

17,200

 

 

 

14,447

 

Inventories

 

10,681

 

 

 

9,529

 

Prepaid expenses and other current assets

 

1,975

 

 

 

1,453

 

Current assets of discontinued operations

 

45,524

 

 

 

41,544

 

Total current assets

 

89,652

 

 

 

83,071

 

Property, plant and equipment, net

 

19,213

 

 

 

19,802

 

Right-of-use assets, operating leases, net

 

27,813

 

 

 

28,225

 

Intangible assets, net

 

6,678

 

 

 

7,009

 

Deferred charges, net

 

297

 

 

 

309

 

Other non-current assets, net

 

860

 

 

 

855

 

Long-term assets of discontinued operations

 

8,029

 

 

 

7,979

 

Total assets

$

152,542

 

 

$

147,250

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

8,989

 

 

$

7,290

 

Accrued expenses and other current liabilities

 

6,344

 

 

 

3,828

 

Current portion of note payable

 

97

 

 

 

369

 

Current portion of operating lease liabilities

 

1,566

 

 

 

1,513

 

Current portion of finance lease liabilities

 

330

 

 

 

334

 

Current liabilities of discontinued operations

 

13,047

 

 

 

8,946

 

Total current liabilities

 

30,373

 

 

 

22,280

 

Long-term portion of operating lease liabilities

 

29,638

 

 

 

30,039

 

Long-term portion of finance lease liabilities

 

939

 

 

 

1,015

 

Deferred income taxes

 

386

 

 

 

320

 

Other long-term liabilities

 

50

 

 

 

51

 

Total non-current liabilities

 

31,013

 

 

 

31,425

 

Total liabilities

$

61,386

 

 

$

53,705

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

Common stock, par value $1 per share; 24,000,000 shares authorized; 11,085,103 and 10,068,406 shares issued and outstanding, respectively

$

11,085

 

 

$

11,085

 

Capital in excess of par value

 

47,335

 

 

 

47,339

 

Retained earnings

 

42,626

 

 

 

44,919

 

 

 

101,046

 

 

 

103,343

 

Less: cost of common stock in treasury - 1,016,697 and 1,012,513 shares, respectively

 

(9,890

)

 

 

(9,798

)

Total shareholders' equity

 

91,156

 

 

 

93,545

 

Total liabilities and shareholders' equity

$

152,542

 

 

$

147,250

 

Note: The condensed consolidated balance sheets at December 31, 2024 have been derived from the audited consolidated financial statements at that date.

Ascent Industries Co.

Condensed Consolidated Statements of Income (Loss) - Comparative Analysis (Unaudited)

($ in thousands, except per share data)

 

 

Three Months Ended

March 31,

 

 

2025

 

 

 

2024

 

Net sales

 

 

 

Tubular Products

$

6,897

 

 

$

7,656

 

Specialty Chemicals

 

17,835

 

 

 

20,296

 

 

 

24,732

 

 

 

27,952

 

Operating income (loss) from continuing operations

 

 

Tubular Products

 

1,004

 

 

 

(54

)

Specialty Chemicals

 

754

 

 

 

(1,439

)

All Other

 

(795

)

 

 

(160

)

 

 

 

 

Corporate

 

 

 

Unallocated corporate expenses

 

(1,995

)

 

 

(2,690

)

Acquisition costs and other

 

(3

)

 

 

 

Total Corporate

 

(1,998

)

 

 

(2,690

)

Operating loss

 

(1,035

)

 

 

(4,343

)

Interest expense, net

 

115

 

 

 

127

 

Other, net

 

(148

)

 

 

(119

)

Loss from continuing operations before income taxes

 

(1,002

)

 

 

(4,351

)

Income tax benefit

 

 

 

 

(585

)

Loss from continuing operations

 

(1,002

)

 

 

(3,766

)

Loss from discontinued operations, net of tax

 

(1,291

)

 

 

(1,727

)

Net loss

$

(2,293

)

 

$

(5,493

)

 

 

 

 

Net loss per common share from continuing operations

 

 

 

Basic

$

(0.10

)

 

$

(0.37

)

Diluted

$

(0.10

)

 

$

(0.37

)

 

 

 

 

Net loss per common share from discontinued operations

 

 

 

Basic

$

(0.13

)

 

$

(0.17

)

Diluted

$

(0.13

)

 

$

(0.17

)

 

 

 

 

Net loss income per common share

 

 

 

Basic

$

(0.23

)

 

$

(0.54

)

Diluted

$

(0.23

)

 

$

(0.54

)

 

 

 

 

Average shares outstanding

 

 

 

Basic

 

10,076

 

 

 

10,094

 

Diluted

 

10,076

 

 

 

10,094

 

 

 

 

 

Other data:

 

 

 

Adjusted EBITDA1

$

844

 

 

$

(2,674

)

1 The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, retention costs and restructuring & severance costs from net income. For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.

 

Ascent Industries Co.

Consolidated Statements of Cash Flows (Unaudited)

($ in thousands)

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

Operating activities

 

 

 

Net loss

$

(2,293

)

 

$

(5,493

)

Loss from discontinued operations, net of tax

 

(1,291

)

 

 

(1,727

)

Net loss from continuing operations

 

(1,002

)

 

 

(3,766

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

Depreciation expense

 

1,099

 

 

 

1,087

 

Amortization expense

 

331

 

 

 

367

 

Amortization of debt issuance costs

 

28

 

 

 

25

 

Deferred income taxes

 

 

 

 

(585

)

(Reduction of) provision for losses on accounts receivable

 

(384

)

 

 

275

 

Non-cash lease expense

 

29

 

 

 

40

 

Stock-based compensation expense

 

118

 

 

 

204

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

(2,369

)

 

 

(1,964

)

Inventories

 

(1,151

)

 

 

3,828

 

Other assets and liabilities

 

(346

)

 

 

(78

)

Accounts payable

 

1,495

 

 

 

1,193

 

Accrued expenses

 

1,941

 

 

 

(121

)

Accrued income taxes

 

(51

)

 

 

79

 

Net cash (used in) provided by operating activities - continuing operations

 

(262

)

 

 

584

 

Net cash used in operating activities - discontinued operations

 

(438

)

 

 

(321

)

Net cash (used in) provided by operating activities

 

(700

)

 

 

263

 

Investing activities

 

 

 

Purchases of property, plant and equipment

 

(322

)

 

 

(238

)

Net cash used in investing activities - continuing operations

 

(322

)

 

 

(238

)

Net cash used in investing activities - discontinued operations

 

(248

)

 

 

(67

)

Net cash used in investing activities

 

(570

)

 

 

(305

)

Financing activities

 

 

 

Borrowings from credit facilities

 

44,571

 

 

 

50,950

 

Payments on credit facilities

 

(44,571

)

 

 

(50,950

)

Payments on note payable

 

(271

)

 

 

(271

)

Principal payments on finance lease obligations

 

(80

)

 

 

(75

)

Repurchase of common stock

 

(215

)

 

 

(163

)

Net cash used in financing activities - continuing operations

 

(566

)

 

 

(509

)

Net cash used in financing activities - discontinued operations

 

 

 

 

(1

)

Net cash used in financing activities

 

(566

)

 

 

(510

)

Decrease in cash and cash equivalents

 

(1,836

)

 

 

(552

)

Less: Cash and cash equivalents of discontinued operations

 

 

 

 

10

 

Cash and cash equivalents, beginning of period

 

16,108

 

 

 

1,841

 

Cash and cash equivalents, end of period

$

14,272

 

 

$

1,299

 

 

Ascent Industries Co.

Non-GAAP Financial Measures Reconciliation

Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited)

($ in thousands)

 

 

Three Months Ended

March 31,

($ in thousands)

 

2025

 

 

 

2024

 

Consolidated

 

 

 

Net loss from continuing operations

$

(1,002

)

 

$

(3,766

)

Adjustments:

 

 

 

Interest expense, net

 

115

 

 

 

127

 

Income taxes

 

 

 

 

(585

)

Depreciation

 

1,099

 

 

 

1,084

 

Amortization

 

331

 

 

 

367

 

EBITDA

 

543

 

 

 

(2,773

)

Acquisition costs and other

 

237

 

 

 

 

Stock-based compensation

 

35

 

 

 

55

 

Non-cash lease expense

 

29

 

 

 

41

 

Retention expense

 

 

 

 

3

 

Adjusted EBITDA

$

844

 

 

$

(2,674

)

% sales

 

3.4

%

 

 

(9.6

)%

Specialty Chemicals

 

 

 

Net income (loss)

$

738

 

 

$

(1,458

)

Adjustments:

 

 

 

Interest expense, net

 

16

 

 

 

19

 

Depreciation

 

962

 

 

 

954

 

Amortization

 

153

 

 

 

169

 

EBITDA

 

1,869

 

 

 

(316

)

Acquisition costs and other

 

92

 

 

 

 

Stock-based compensation

 

 

 

 

7

 

Non-cash lease expense

 

9

 

 

 

19

 

Specialty Chemicals Adjusted EBITDA

$

1,970

 

 

$

(290

)

% segment sales

 

11.0

%

 

 

(1.4

)%

 

 

 

 

Tubular Products

 

 

 

Net income (loss) from continuing operations

$

1,004

 

 

$

(54

)

Adjustments:

 

 

 

Interest expense, net

 

1

 

 

 

 

Depreciation

 

121

 

 

 

109

 

Amortization

 

178

 

 

 

198

 

EBITDA

 

1,304

 

 

 

253

 

Stock-based compensation

 

 

 

 

5

 

Non-cash lease expense

 

5

 

 

 

10

 

Tubular Products Adjusted EBITDA

$

1,309

 

 

$

268

 

% segment sales

 

19.0

%

 

 

3.5

%

 

Powered by EIN Presswire

Distribution channels:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release